Quick Answer
Evogene Ltd. reported Total Assets of $20.05 million for fiscal year 2025.
Evogene Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $20.05M | -49.7% |
| 2024 | $39.86M | -22.0% |
| 2023 | $51.10M | -9.0% |
| 2022 | $56.13M | -26.4% |
| 2021 | $76.30M | +6.1% |
| 2020 | $71.92M | +0.8% |
| 2019 | $71.36M | +21.6% |
| 2018 | $58.69M | -24.4% |
| 2017 | $77.60M | -19.2% |
| 2016 | $95.99M | — |
- Evogene Ltd. showed a decrease of -49.7% in Total Assets compared to the prior fiscal year.
- Over the 2016–2025 period, Evogene Ltd.’s total assets has declined by 79.1% (from $95.99 million to $20.05 million).
- The most recent figure is from Evogene Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: